FdaApplication
NDA 020692
Identifiers
- fda_app_no: NDA020692
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY LTD ENGLAND |
| application_type | NDA |
| approval_date | 1997-09-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEREVENT | SALMETEROL XINAFOATE | EQ 0.05MG BASE/INH | POWDER;INHALATION |
1 product